Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. My colleague Adam Feuerstein and I spent the day yesterday listening to the FDA advisory committee meeting on Lilly’s Alzheimer’s candidate. Read on for the outcome of the meeting, and also, who’s behind yet another new obesity startup.